Luck, SE;
Wieringa, JW;
Blazquez-Gamero, D;
Henneke, P;
Schuster, K;
Butler, K;
Capretti, MG;
... Vossen, ACTM; + view all
(2017)
Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management.
The Pediatric Infectious Disease Journal
, 36
(12)
pp. 1205-1213.
10.1097/INF.0000000000001763.
Preview |
Text
Klein_resubmission May 2017.pdf - Accepted Version Download (820kB) | Preview |
Abstract
Congenital cytomegalovirus (cCMV) is the most common congenital infection in the developed world. Reported prevalence varies between cohorts but is approximately 7 per 1000 births.1 About half of cytomegalovirus (CMV)-infected babies with clinically detectable disease at birth are destined to have significant impairments in their development, and cCMV infection is implicated in approximately 25% of all children with sensorineural hearing loss (SNHL).1,2 Meta-analysis shows that although long-term sequelae, especially SNHL, are more common in those with clinically detectable disease at birth, they are also found in 13% of those without clinical features attributable to CMV on initial examination.1
Archive Staff Only
 |
View Item |
